Custom oligos used to perform critical experiments for the lab for ongoing research that started prior to january 20, 2025 as not to lose investment in research studies focus on discovering the…
Ended Awarded Last action
- Contract number
- 75N95A25F00003
- Awardee
-
Eurofins Genomics LLC UEI GE75H6G8HKM5
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,500
Award facts
- Contract value 100% obligated
- $7,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Jeffersontown, KY 40299, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Eurofins Genomics LLC, a for-profit manufacturer of goods based in Louisville, Kentucky. The $7,500 firm fixed price contract is a Blanket Purchase Agreement (BPA) call order for the delivery of custom oligonucleotides to support ongoing critical research experiments at the agency's lab. The research focuses on discovering the functions and interrelationships among proteins mutated. This award is part of a larger $100,000,000 single-award BPA with NINDS that enables the agency to rapidly procure critical genomic research materials. The contract does not have a set-aside designation, indicating open competition. Eurofins Genomics has demonstrated significant capability in supporting biomedical research and pandemic response efforts across multiple federal departments.
Description
Custom oligos used to perform critical experiments for the lab for ongoing research that started prior to january 20, 2025 as not to lose investment in research studies focus on discovering the functions and interrelationships among proteins mutated
Quick answers
Who was awarded contract 75N95A25F00003?
75N95A25F00003 was awarded to Eurofins Genomics LLC by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on December 19, 2024.
How much is contract 75N95A25F00003 worth?
The government has obligated $7,500 on 75N95A25F00003.
Is contract 75N95A25F00003 an order under another contract?
Yes. 75N95A25F00003 is a BPA call under 75N98024A00124, a blanket purchase agreement.
Was contract 75N95A25F00003 competed?
The extent of competition for 75N95A25F00003 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award